Strata Skin Sciences, Inc.
SSKN
$2.72
-$0.17-5.88%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.39% | -16.48% | -93.18% | -95.17% | -15.36% |
| Total Depreciation and Amortization | -10.60% | -4.42% | -0.62% | 3.76% | 12.04% |
| Total Amortization of Deferred Charges | -10.46% | -22.56% | -19.25% | -10.83% | 0.00% |
| Total Other Non-Cash Items | 43.99% | 43.02% | 197.80% | 160.54% | 36.94% |
| Change in Net Operating Assets | 167.80% | 8.04% | 122.42% | 102.29% | -124.35% |
| Cash from Operations | 157.92% | -88.83% | 73.27% | 58.44% | -294.24% |
| Capital Expenditure | 40.30% | 52.30% | 15.71% | -37.96% | -57.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Investing | 40.30% | 52.30% | 15.71% | -18.02% | -31.65% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.18% | 77.20% | 68.60% | 72.20% | -- |
| Cash from Financing | -69.74% | -101.89% | 1,468.60% | 1,472.20% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.29% | -1,096.66% | 135.40% | 122.85% | 91.73% |
